Monitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current Applications and Emerging Approaches

Approaches such as digital PCR have demonstrated improved, assay characteristics and are likely to play an increasing role in the monitoring of myeloproliferative neoplasms. While next-generation sequencing is increasingly valuable as a tool for the diagnosis of myeloproliferative neoplasms, its role in the assessment of minimal residual disease requires further evaluation.

 Biomed Res Int